AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
A super-high yield isn't everything.
AbbVie (ABBV) stock news
Every headline mentioning AbbVie from Yahoo Finance and BioPharma Dive over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines2last 7 days · 3 in 30 days
Sentiment, 30 days
2 positive1 neutral0 negative
Latest headlineSun 11 Oct, 09:04 UTCHealthcare
Latest ABBV headlines
Sunday, 11 October 2026
Tuesday, 6 October 2026
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
The better-than-expected results could make Epkinly the new “undisputed” treatment standard in newly diagnosed DLBCL, according to one analyst.